Related Experiment Video
Updated: May 13, 2026
12:40
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
Modeling Huntington's disease with induced pluripotent stem cells
Julia A Kaye1, Steven Finkbeiner
1Gladstone Institute of Neurological Disease, 1650 Owens Street, San Francisco, CA 94158, United States.
Molecular and Cellular Neurosciences
|March 6, 2013
Summary
Induced pluripotent stem cells (iPSCs) offer a novel human-based model for studying Huntington's disease (HD) pathogenesis. Research explores differentiating iPSCs into affected neurons to understand early disease mechanisms and potential cell therapies.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Genetics
Background:
- Huntington's disease (HD) is a fatal neurodegenerative disorder characterized by motor, cognitive, and behavioral deficits.
- Traditional research relies on animal models, limiting direct human insights into HD pathogenesis.
- Induced pluripotent stem cells (iPSCs) provide a patient-specific, human cell-based platform for disease modeling.
Purpose of the Study:
- To examine the implementation of iPSCs for studying Huntington's disease.
- To investigate the differentiation of iPSCs and embryonic stem cells (ESCs) into medium spiny neurons, the primary cell type affected in HD.
- To explore early alterations in brain development and neurogenesis in HD models.
Main Methods:
- Utilizing induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) derived from patients.
- Differentiating stem cells into medium spiny neurons.
- Analyzing HD-related phenotypes in patient-derived neuronal cells.
Main Results:
- Identification of specific HD-related phenotypes in iPSC and ESC-derived neurons.
- Potential evidence of early disruptions in neurogenesis and brain development preceding clinical HD symptoms.
- Demonstration of iPSCs as a viable model for studying HD molecular pathology.
Conclusions:
- iPSCs offer a powerful human-cell-based platform for understanding Huntington's disease.
- Early developmental alterations may contribute to HD pathogenesis, offering targets for therapeutic intervention.
- Stem cell-based approaches hold promise for future Huntington's disease therapeutics, including cell replacement strategies.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...